Browsing by Author Newton, Michael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial
Journal:Lung Cancer
Naidoo, JarushkaVansteenkiste, Johan F.Faivre-Finn, CorinneÖzgüroğlu, MustafaMurakami, ShujiHui, RinaQuantin, XavierBroadhurst, HelenNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J.
2022
 
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)
Journal:Clinical Lung Cancer
Socinski, Mark A.Özgüroğlu, MustafaVillegas, AugustoDaniel, DaveyVicente, DavidMurakami, ShujiHui, RinaGray, Jhanelle E.Park, KeunchilVincent, MarkMann, HelenNewton, MichaelDennis, Phillip A.Antonia, Scott J.
2021
 
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Journal:Journal of Clinical Oncology
Spigel, David R.Faivre-Finn, CorinneGray, Jhanelle E.Vicente, DavidPlanchard, DavidPaz-Ares, LuisVansteenkiste, Johan F.Garassino, Marina C.Hui, RinaQuantin, XavierRimner, AndreasWu, Yi LongÖzgüroǧlu, MustafaLee, Ki H.Kato, TerufumiDe Wit, MaikeKurata, TakayasuReck, MartinCho, Byoung C.Senan, SureshNaidoo, JarushkaMann, HelenNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J.
2022
 
Symptomatic Pneumonitis with Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small-Cell Lung Cancer
Journal:JTO Clinical and Research Reports
Vansteenkiste, Johan FNaidoo, JarushkaFaivre–Finn, CorinneÖzgüroğlu, MustafaVillegas, AugustoDaniel, DaveyMurakami, ShujiHui, RinaLee, Ki HyeongCho, Byoung ChulKubota, KaoruBroadhurst, HelenWadsworth, CatherineNewton, MichaelThiyagarajah, PirunthaAntonia, Scott J
17-Jan-2024
Showing results 1 to 4 of 4